{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/R",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Respira\u010Dn\u00ED syst\u00E9m" , "@language" : "cs" } ,        { "@value" : "RESPIRATORY SYSTEM" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "R" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/R03",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "L\u00E9\u010Diva k terapii onemocn\u011Bn\u00ED spojen\u00FDch s obstrukc\u00ED d\u00FDchac\u00EDch cest" , "@language" : "cs" } ,        { "@value" : "DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "R03" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/R03D",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES" , "@language" : "en" } ,        { "@value" : "Jin\u00E1 syst\u00E9mov\u00E1 l\u00E9\u010Diva onemocn\u011Bn\u00ED spojen. s obstrukc\u00ED d\u00FDch. cest" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "R03D" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/R03DC",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Leukotriene receptor antagonists" , "@language" : "en" } ,        { "@value" : "Antagonist\u00E9 leukotrienov\u00FDch receptor\u016F" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "R03DC" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/R03DC03",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/R" ,        "http://linked.opendata.cz/resource/ATC/R03" ,        "http://linked.opendata.cz/resource/ATC/R03DC" ,        "http://linked.opendata.cz/resource/ATC/R03D" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Montelukast" , "@language" : "en" } ,        { "@value" : "Montelukast" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "R03DC03" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0326949",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Montelukast sodium" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/B" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/MONTELUKAST-TEVA-4-MG--ZVYKACI-TABLETA",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0326949" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MONTELUKAST TEVA 4 MG, \u017DV\u00DDKAC\u00CD TABLETA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/R03DC03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPregnancyCategory" : [ "http://linked.opendata.cz/resource/fda-spl/pregnancy-category/B" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117464" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117463" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117462" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117461" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117460" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117459" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117458" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117455" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117456" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117457" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117454" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117453" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117464",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MONTELUKAST TEVA 4 MG, \u017DV\u00DDKAC\u00CD TABLETA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/R03DC03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "BRONCHODILATANTIA, ANTIASTHMATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC141835_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "100" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "4MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Montelukast je ur\u010Den jako p\u0159\u00EDdavn\u00E1 terapie k\u00A0l\u00E9\u010Db\u011B pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm a\u017E st\u0159edn\u011B t\u011B\u017Ek\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED jsou nedostate\u010Dn\u011B kontrolov\u00E1ni inhala\u010Dn\u00EDmi kortikosteroidy a u nich\u017E kr\u00E1tkodob\u011B p\u016Fsob\u00EDc\u00ED \u03B2-agonist\u00E9 podan\u00ED \u201Epodle pot\u0159eby\u201C neposkytuj\u00ED dostate\u010Dnou klinickou kontrolu astmatu. \nMontelukast m\u016F\u017Ee b\u00FDt t\u00E9\u017E alternativou k\u00A0l\u00E9\u010Db\u011B n\u00EDzko d\u00E1vkovan\u00FDmi inhala\u010Dn\u00EDmi kortikosteroidy u pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED nemaj\u00ED v\u00A0ned\u00E1vn\u00E9 anamn\u00E9ze t\u011B\u017Ek\u00E9 astmatick\u00E9 z\u00E1chvaty vy\u017Eaduj\u00EDc\u00ED peror\u00E1ln\u00ED kortikosteroidy, a kte\u0159\u00ED nejsou schopni u\u017E\u00EDvat inhala\u010Dn\u00ED kortikosteroidy (viz bod 4.2).\nMontelukast je rovn\u011B\u017E indikov\u00E1n k\u00A0profylaxi astmatu pro pacienty od 2 let a star\u0161\u00ED, pokud je rozhoduj\u00EDc\u00ED slo\u017Ekou bronchokonstrikce indukovan\u00E1 t\u011Blesnou n\u00E1mahou.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL MND 100X4MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117463",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MONTELUKAST TEVA 4 MG, \u017DV\u00DDKAC\u00CD TABLETA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/R03DC03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "BRONCHODILATANTIA, ANTIASTHMATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC141835_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "98" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "4MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Montelukast je ur\u010Den jako p\u0159\u00EDdavn\u00E1 terapie k\u00A0l\u00E9\u010Db\u011B pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm a\u017E st\u0159edn\u011B t\u011B\u017Ek\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED jsou nedostate\u010Dn\u011B kontrolov\u00E1ni inhala\u010Dn\u00EDmi kortikosteroidy a u nich\u017E kr\u00E1tkodob\u011B p\u016Fsob\u00EDc\u00ED \u03B2-agonist\u00E9 podan\u00ED \u201Epodle pot\u0159eby\u201C neposkytuj\u00ED dostate\u010Dnou klinickou kontrolu astmatu. \nMontelukast m\u016F\u017Ee b\u00FDt t\u00E9\u017E alternativou k\u00A0l\u00E9\u010Db\u011B n\u00EDzko d\u00E1vkovan\u00FDmi inhala\u010Dn\u00EDmi kortikosteroidy u pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED nemaj\u00ED v\u00A0ned\u00E1vn\u00E9 anamn\u00E9ze t\u011B\u017Ek\u00E9 astmatick\u00E9 z\u00E1chvaty vy\u017Eaduj\u00EDc\u00ED peror\u00E1ln\u00ED kortikosteroidy, a kte\u0159\u00ED nejsou schopni u\u017E\u00EDvat inhala\u010Dn\u00ED kortikosteroidy (viz bod 4.2).\nMontelukast je rovn\u011B\u017E indikov\u00E1n k\u00A0profylaxi astmatu pro pacienty od 2 let a star\u0161\u00ED, pokud je rozhoduj\u00EDc\u00ED slo\u017Ekou bronchokonstrikce indukovan\u00E1 t\u011Blesnou n\u00E1mahou.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasResumedMarketingDate" : [ { "@value" : "2012-05-15" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 1800.0400390625 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 1866.400024414062 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL MND 98X4MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117462",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MONTELUKAST TEVA 4 MG, \u017DV\u00DDKAC\u00CD TABLETA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/R03DC03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "BRONCHODILATANTIA, ANTIASTHMATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC141835_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "90" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "4MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Montelukast je ur\u010Den jako p\u0159\u00EDdavn\u00E1 terapie k\u00A0l\u00E9\u010Db\u011B pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm a\u017E st\u0159edn\u011B t\u011B\u017Ek\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED jsou nedostate\u010Dn\u011B kontrolov\u00E1ni inhala\u010Dn\u00EDmi kortikosteroidy a u nich\u017E kr\u00E1tkodob\u011B p\u016Fsob\u00EDc\u00ED \u03B2-agonist\u00E9 podan\u00ED \u201Epodle pot\u0159eby\u201C neposkytuj\u00ED dostate\u010Dnou klinickou kontrolu astmatu. \nMontelukast m\u016F\u017Ee b\u00FDt t\u00E9\u017E alternativou k\u00A0l\u00E9\u010Db\u011B n\u00EDzko d\u00E1vkovan\u00FDmi inhala\u010Dn\u00EDmi kortikosteroidy u pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED nemaj\u00ED v\u00A0ned\u00E1vn\u00E9 anamn\u00E9ze t\u011B\u017Ek\u00E9 astmatick\u00E9 z\u00E1chvaty vy\u017Eaduj\u00EDc\u00ED peror\u00E1ln\u00ED kortikosteroidy, a kte\u0159\u00ED nejsou schopni u\u017E\u00EDvat inhala\u010Dn\u00ED kortikosteroidy (viz bod 4.2).\nMontelukast je rovn\u011B\u017E indikov\u00E1n k\u00A0profylaxi astmatu pro pacienty od 2 let a star\u0161\u00ED, pokud je rozhoduj\u00EDc\u00ED slo\u017Ekou bronchokonstrikce indukovan\u00E1 t\u011Blesnou n\u00E1mahou.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL MND 90X4MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117461",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MONTELUKAST TEVA 4 MG, \u017DV\u00DDKAC\u00CD TABLETA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/R03DC03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "BRONCHODILATANTIA, ANTIASTHMATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC141835_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "60" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "4MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Montelukast je ur\u010Den jako p\u0159\u00EDdavn\u00E1 terapie k\u00A0l\u00E9\u010Db\u011B pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm a\u017E st\u0159edn\u011B t\u011B\u017Ek\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED jsou nedostate\u010Dn\u011B kontrolov\u00E1ni inhala\u010Dn\u00EDmi kortikosteroidy a u nich\u017E kr\u00E1tkodob\u011B p\u016Fsob\u00EDc\u00ED \u03B2-agonist\u00E9 podan\u00ED \u201Epodle pot\u0159eby\u201C neposkytuj\u00ED dostate\u010Dnou klinickou kontrolu astmatu. \nMontelukast m\u016F\u017Ee b\u00FDt t\u00E9\u017E alternativou k\u00A0l\u00E9\u010Db\u011B n\u00EDzko d\u00E1vkovan\u00FDmi inhala\u010Dn\u00EDmi kortikosteroidy u pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED nemaj\u00ED v\u00A0ned\u00E1vn\u00E9 anamn\u00E9ze t\u011B\u017Ek\u00E9 astmatick\u00E9 z\u00E1chvaty vy\u017Eaduj\u00EDc\u00ED peror\u00E1ln\u00ED kortikosteroidy, a kte\u0159\u00ED nejsou schopni u\u017E\u00EDvat inhala\u010Dn\u00ED kortikosteroidy (viz bod 4.2).\nMontelukast je rovn\u011B\u017E indikov\u00E1n k\u00A0profylaxi astmatu pro pacienty od 2 let a star\u0161\u00ED, pokud je rozhoduj\u00EDc\u00ED slo\u017Ekou bronchokonstrikce indukovan\u00E1 t\u011Blesnou n\u00E1mahou.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL MND 60X4MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117460",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MONTELUKAST TEVA 4 MG, \u017DV\u00DDKAC\u00CD TABLETA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/R03DC03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "BRONCHODILATANTIA, ANTIASTHMATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC141835_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "56" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "4MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Montelukast je ur\u010Den jako p\u0159\u00EDdavn\u00E1 terapie k\u00A0l\u00E9\u010Db\u011B pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm a\u017E st\u0159edn\u011B t\u011B\u017Ek\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED jsou nedostate\u010Dn\u011B kontrolov\u00E1ni inhala\u010Dn\u00EDmi kortikosteroidy a u nich\u017E kr\u00E1tkodob\u011B p\u016Fsob\u00EDc\u00ED \u03B2-agonist\u00E9 podan\u00ED \u201Epodle pot\u0159eby\u201C neposkytuj\u00ED dostate\u010Dnou klinickou kontrolu astmatu. \nMontelukast m\u016F\u017Ee b\u00FDt t\u00E9\u017E alternativou k\u00A0l\u00E9\u010Db\u011B n\u00EDzko d\u00E1vkovan\u00FDmi inhala\u010Dn\u00EDmi kortikosteroidy u pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED nemaj\u00ED v\u00A0ned\u00E1vn\u00E9 anamn\u00E9ze t\u011B\u017Ek\u00E9 astmatick\u00E9 z\u00E1chvaty vy\u017Eaduj\u00EDc\u00ED peror\u00E1ln\u00ED kortikosteroidy, a kte\u0159\u00ED nejsou schopni u\u017E\u00EDvat inhala\u010Dn\u00ED kortikosteroidy (viz bod 4.2).\nMontelukast je rovn\u011B\u017E indikov\u00E1n k\u00A0profylaxi astmatu pro pacienty od 2 let a star\u0161\u00ED, pokud je rozhoduj\u00EDc\u00ED slo\u017Ekou bronchokonstrikce indukovan\u00E1 t\u011Blesnou n\u00E1mahou.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL MND 56X4MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117459",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MONTELUKAST TEVA 4 MG, \u017DV\u00DDKAC\u00CD TABLETA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/R03DC03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "BRONCHODILATANTIA, ANTIASTHMATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC141835_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "50" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "4MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Montelukast je ur\u010Den jako p\u0159\u00EDdavn\u00E1 terapie k\u00A0l\u00E9\u010Db\u011B pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm a\u017E st\u0159edn\u011B t\u011B\u017Ek\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED jsou nedostate\u010Dn\u011B kontrolov\u00E1ni inhala\u010Dn\u00EDmi kortikosteroidy a u nich\u017E kr\u00E1tkodob\u011B p\u016Fsob\u00EDc\u00ED \u03B2-agonist\u00E9 podan\u00ED \u201Epodle pot\u0159eby\u201C neposkytuj\u00ED dostate\u010Dnou klinickou kontrolu astmatu. \nMontelukast m\u016F\u017Ee b\u00FDt t\u00E9\u017E alternativou k\u00A0l\u00E9\u010Db\u011B n\u00EDzko d\u00E1vkovan\u00FDmi inhala\u010Dn\u00EDmi kortikosteroidy u pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED nemaj\u00ED v\u00A0ned\u00E1vn\u00E9 anamn\u00E9ze t\u011B\u017Ek\u00E9 astmatick\u00E9 z\u00E1chvaty vy\u017Eaduj\u00EDc\u00ED peror\u00E1ln\u00ED kortikosteroidy, a kte\u0159\u00ED nejsou schopni u\u017E\u00EDvat inhala\u010Dn\u00ED kortikosteroidy (viz bod 4.2).\nMontelukast je rovn\u011B\u017E indikov\u00E1n k\u00A0profylaxi astmatu pro pacienty od 2 let a star\u0161\u00ED, pokud je rozhoduj\u00EDc\u00ED slo\u017Ekou bronchokonstrikce indukovan\u00E1 t\u011Blesnou n\u00E1mahou.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL MND 50X4MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117458",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MONTELUKAST TEVA 4 MG, \u017DV\u00DDKAC\u00CD TABLETA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/R03DC03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "BRONCHODILATANTIA, ANTIASTHMATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC141835_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "30" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "4MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Montelukast je ur\u010Den jako p\u0159\u00EDdavn\u00E1 terapie k\u00A0l\u00E9\u010Db\u011B pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm a\u017E st\u0159edn\u011B t\u011B\u017Ek\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED jsou nedostate\u010Dn\u011B kontrolov\u00E1ni inhala\u010Dn\u00EDmi kortikosteroidy a u nich\u017E kr\u00E1tkodob\u011B p\u016Fsob\u00EDc\u00ED \u03B2-agonist\u00E9 podan\u00ED \u201Epodle pot\u0159eby\u201C neposkytuj\u00ED dostate\u010Dnou klinickou kontrolu astmatu. \nMontelukast m\u016F\u017Ee b\u00FDt t\u00E9\u017E alternativou k\u00A0l\u00E9\u010Db\u011B n\u00EDzko d\u00E1vkovan\u00FDmi inhala\u010Dn\u00EDmi kortikosteroidy u pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED nemaj\u00ED v\u00A0ned\u00E1vn\u00E9 anamn\u00E9ze t\u011B\u017Ek\u00E9 astmatick\u00E9 z\u00E1chvaty vy\u017Eaduj\u00EDc\u00ED peror\u00E1ln\u00ED kortikosteroidy, a kte\u0159\u00ED nejsou schopni u\u017E\u00EDvat inhala\u010Dn\u00ED kortikosteroidy (viz bod 4.2).\nMontelukast je rovn\u011B\u017E indikov\u00E1n k\u00A0profylaxi astmatu pro pacienty od 2 let a star\u0161\u00ED, pokud je rozhoduj\u00EDc\u00ED slo\u017Ekou bronchokonstrikce indukovan\u00E1 t\u011Blesnou n\u00E1mahou.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL MND 30X4MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117455",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MONTELUKAST TEVA 4 MG, \u017DV\u00DDKAC\u00CD TABLETA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/R03DC03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "BRONCHODILATANTIA, ANTIASTHMATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC141835_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "15" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "4MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Montelukast je ur\u010Den jako p\u0159\u00EDdavn\u00E1 terapie k\u00A0l\u00E9\u010Db\u011B pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm a\u017E st\u0159edn\u011B t\u011B\u017Ek\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED jsou nedostate\u010Dn\u011B kontrolov\u00E1ni inhala\u010Dn\u00EDmi kortikosteroidy a u nich\u017E kr\u00E1tkodob\u011B p\u016Fsob\u00EDc\u00ED \u03B2-agonist\u00E9 podan\u00ED \u201Epodle pot\u0159eby\u201C neposkytuj\u00ED dostate\u010Dnou klinickou kontrolu astmatu. \nMontelukast m\u016F\u017Ee b\u00FDt t\u00E9\u017E alternativou k\u00A0l\u00E9\u010Db\u011B n\u00EDzko d\u00E1vkovan\u00FDmi inhala\u010Dn\u00EDmi kortikosteroidy u pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED nemaj\u00ED v\u00A0ned\u00E1vn\u00E9 anamn\u00E9ze t\u011B\u017Ek\u00E9 astmatick\u00E9 z\u00E1chvaty vy\u017Eaduj\u00EDc\u00ED peror\u00E1ln\u00ED kortikosteroidy, a kte\u0159\u00ED nejsou schopni u\u017E\u00EDvat inhala\u010Dn\u00ED kortikosteroidy (viz bod 4.2).\nMontelukast je rovn\u011B\u017E indikov\u00E1n k\u00A0profylaxi astmatu pro pacienty od 2 let a star\u0161\u00ED, pokud je rozhoduj\u00EDc\u00ED slo\u017Ekou bronchokonstrikce indukovan\u00E1 t\u011Blesnou n\u00E1mahou.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL MND 15X4MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117456",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MONTELUKAST TEVA 4 MG, \u017DV\u00DDKAC\u00CD TABLETA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/R03DC03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "BRONCHODILATANTIA, ANTIASTHMATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC141835_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "20" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "4MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Montelukast je ur\u010Den jako p\u0159\u00EDdavn\u00E1 terapie k\u00A0l\u00E9\u010Db\u011B pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm a\u017E st\u0159edn\u011B t\u011B\u017Ek\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED jsou nedostate\u010Dn\u011B kontrolov\u00E1ni inhala\u010Dn\u00EDmi kortikosteroidy a u nich\u017E kr\u00E1tkodob\u011B p\u016Fsob\u00EDc\u00ED \u03B2-agonist\u00E9 podan\u00ED \u201Epodle pot\u0159eby\u201C neposkytuj\u00ED dostate\u010Dnou klinickou kontrolu astmatu. \nMontelukast m\u016F\u017Ee b\u00FDt t\u00E9\u017E alternativou k\u00A0l\u00E9\u010Db\u011B n\u00EDzko d\u00E1vkovan\u00FDmi inhala\u010Dn\u00EDmi kortikosteroidy u pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED nemaj\u00ED v\u00A0ned\u00E1vn\u00E9 anamn\u00E9ze t\u011B\u017Ek\u00E9 astmatick\u00E9 z\u00E1chvaty vy\u017Eaduj\u00EDc\u00ED peror\u00E1ln\u00ED kortikosteroidy, a kte\u0159\u00ED nejsou schopni u\u017E\u00EDvat inhala\u010Dn\u00ED kortikosteroidy (viz bod 4.2).\nMontelukast je rovn\u011B\u017E indikov\u00E1n k\u00A0profylaxi astmatu pro pacienty od 2 let a star\u0161\u00ED, pokud je rozhoduj\u00EDc\u00ED slo\u017Ekou bronchokonstrikce indukovan\u00E1 t\u011Blesnou n\u00E1mahou.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL MND 20X4MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117457",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MONTELUKAST TEVA 4 MG, \u017DV\u00DDKAC\u00CD TABLETA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/R03DC03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "BRONCHODILATANTIA, ANTIASTHMATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC141835_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "28" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "4MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Montelukast je ur\u010Den jako p\u0159\u00EDdavn\u00E1 terapie k\u00A0l\u00E9\u010Db\u011B pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm a\u017E st\u0159edn\u011B t\u011B\u017Ek\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED jsou nedostate\u010Dn\u011B kontrolov\u00E1ni inhala\u010Dn\u00EDmi kortikosteroidy a u nich\u017E kr\u00E1tkodob\u011B p\u016Fsob\u00EDc\u00ED \u03B2-agonist\u00E9 podan\u00ED \u201Epodle pot\u0159eby\u201C neposkytuj\u00ED dostate\u010Dnou klinickou kontrolu astmatu. \nMontelukast m\u016F\u017Ee b\u00FDt t\u00E9\u017E alternativou k\u00A0l\u00E9\u010Db\u011B n\u00EDzko d\u00E1vkovan\u00FDmi inhala\u010Dn\u00EDmi kortikosteroidy u pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED nemaj\u00ED v\u00A0ned\u00E1vn\u00E9 anamn\u00E9ze t\u011B\u017Ek\u00E9 astmatick\u00E9 z\u00E1chvaty vy\u017Eaduj\u00EDc\u00ED peror\u00E1ln\u00ED kortikosteroidy, a kte\u0159\u00ED nejsou schopni u\u017E\u00EDvat inhala\u010Dn\u00ED kortikosteroidy (viz bod 4.2).\nMontelukast je rovn\u011B\u017E indikov\u00E1n k\u00A0profylaxi astmatu pro pacienty od 2 let a star\u0161\u00ED, pokud je rozhoduj\u00EDc\u00ED slo\u017Ekou bronchokonstrikce indukovan\u00E1 t\u011Blesnou n\u00E1mahou.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasResumedMarketingDate" : [ { "@value" : "2012-05-15" , "@type" : "http://www.w3.org/2001/XMLSchema#date" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 533.260009765625 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 533.260009765625 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL MND 28X4MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117454",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MONTELUKAST TEVA 4 MG, \u017DV\u00DDKAC\u00CD TABLETA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/R03DC03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "BRONCHODILATANTIA, ANTIASTHMATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC141835_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "14" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "4MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Montelukast je ur\u010Den jako p\u0159\u00EDdavn\u00E1 terapie k\u00A0l\u00E9\u010Db\u011B pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm a\u017E st\u0159edn\u011B t\u011B\u017Ek\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED jsou nedostate\u010Dn\u011B kontrolov\u00E1ni inhala\u010Dn\u00EDmi kortikosteroidy a u nich\u017E kr\u00E1tkodob\u011B p\u016Fsob\u00EDc\u00ED \u03B2-agonist\u00E9 podan\u00ED \u201Epodle pot\u0159eby\u201C neposkytuj\u00ED dostate\u010Dnou klinickou kontrolu astmatu. \nMontelukast m\u016F\u017Ee b\u00FDt t\u00E9\u017E alternativou k\u00A0l\u00E9\u010Db\u011B n\u00EDzko d\u00E1vkovan\u00FDmi inhala\u010Dn\u00EDmi kortikosteroidy u pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED nemaj\u00ED v\u00A0ned\u00E1vn\u00E9 anamn\u00E9ze t\u011B\u017Ek\u00E9 astmatick\u00E9 z\u00E1chvaty vy\u017Eaduj\u00EDc\u00ED peror\u00E1ln\u00ED kortikosteroidy, a kte\u0159\u00ED nejsou schopni u\u017E\u00EDvat inhala\u010Dn\u00ED kortikosteroidy (viz bod 4.2).\nMontelukast je rovn\u011B\u017E indikov\u00E1n k\u00A0profylaxi astmatu pro pacienty od 2 let a star\u0161\u00ED, pokud je rozhoduj\u00EDc\u00ED slo\u017Ekou bronchokonstrikce indukovan\u00E1 t\u011Blesnou n\u00E1mahou.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL MND 14X4MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0117453",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MONTELUKAST TEVA 4 MG, \u017DV\u00DDKAC\u00CD TABLETA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/R03DC03" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "BRONCHODILATANTIA, ANTIASTHMATICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC141835_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "7" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "4MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Montelukast je ur\u010Den jako p\u0159\u00EDdavn\u00E1 terapie k\u00A0l\u00E9\u010Db\u011B pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm a\u017E st\u0159edn\u011B t\u011B\u017Ek\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED jsou nedostate\u010Dn\u011B kontrolov\u00E1ni inhala\u010Dn\u00EDmi kortikosteroidy a u nich\u017E kr\u00E1tkodob\u011B p\u016Fsob\u00EDc\u00ED \u03B2-agonist\u00E9 podan\u00ED \u201Epodle pot\u0159eby\u201C neposkytuj\u00ED dostate\u010Dnou klinickou kontrolu astmatu. \nMontelukast m\u016F\u017Ee b\u00FDt t\u00E9\u017E alternativou k\u00A0l\u00E9\u010Db\u011B n\u00EDzko d\u00E1vkovan\u00FDmi inhala\u010Dn\u00EDmi kortikosteroidy u pacient\u016F ve v\u011Bku od 2 do 5 let s\u00A0lehk\u00FDm persistuj\u00EDc\u00EDm astmatem, kte\u0159\u00ED nemaj\u00ED v\u00A0ned\u00E1vn\u00E9 anamn\u00E9ze t\u011B\u017Ek\u00E9 astmatick\u00E9 z\u00E1chvaty vy\u017Eaduj\u00EDc\u00ED peror\u00E1ln\u00ED kortikosteroidy, a kte\u0159\u00ED nejsou schopni u\u017E\u00EDvat inhala\u010Dn\u00ED kortikosteroidy (viz bod 4.2).\nMontelukast je rovn\u011B\u017E indikov\u00E1n k\u00A0profylaxi astmatu pro pacienty od 2 let a star\u0161\u00ED, pokud je rozhoduj\u00EDc\u00ED slo\u017Ekou bronchokonstrikce indukovan\u00E1 t\u011Blesnou n\u00E1mahou.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL MND 7X4MG" , "@language" : "cs" } ] }] }